January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
The use of TDXd for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer – Dana-Farber’s Breast Oncology Center
Oct 15, 2024, 19:00

The use of TDXd for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

Check out our newest treatment guideline on the use of trastuzumab deruxtecan (TDXd) for patients with Metastatic, HER2-low and HER2-ultralow Breast Cancer.”

More posts featuring Dana-Farber’s Breast Oncology Center.